Cardiovascular Outcomes Among ESRD Patients Undergoing Kidney Transplantation

Transplant Proc. 2026 Aug 19:S0041-1345(26)00363-5. doi: 10.1016/j.transproceed.2026.07.020. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic kidney disease (CKD) following kidney transplantation (KT). Despite recommendat

Y Yaacov Goykhman

Natriuretic peptide responses to exercise in HFpEF diagnosis: a pilot study

Open Heart. 2026 Aug 19;13(2):e004313. doi: 10.1136/openhrt-2026-004313.ABSTRACTBACKGROUND: Diagnosing heart failure with preserved ejection fraction (HFpEF) can be challenging because natriuretic peptide (NP) plasma levels and diastolic function parameters during rest echocardiography may be normal

A Anne Margje Lisa Naomi van Ommen

Navigating Colchicine Toxicity: Essential Management for a Timeless Therapy

J Emerg Nurs. 2026 Sep;52(5):1125-1131. doi: 10.1016/j.jen.2026.03.003.ABSTRACTINTRODUCTION: Colchicine has been used for centuries in the management of gout and familial Mediterranean fever. Its clinical applications now extend to pericarditis, systemic inflammatory conditions, and the prevention o

N Nancy J Denke